Riik: Euroopa Liit
keel: inglise
Allikas: EMA (European Medicines Agency)
Roxadustat
Astellas Pharma Europe B.V.
B03XA05
roxadustat
Antianemic preparations
Anemia; Kidney Failure, Chronic
Evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (CKD).
Revision: 3
Authorised
2021-08-18
44 B. PACKAGE LEAFLET 45 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT EVRENZO 20 MG FILM-COATED TABLETS EVRENZO 50 MG FILM-COATED TABLETS EVRENZO 70 MG FILM-COATED TABLETS EVRENZO 100 MG FILM-COATED TABLETS EVRENZO 150 MG FILM-COATED TABLETS roxadustat This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Evrenzo is and what it is used for 2. What you need to know before you take Evrenzo 3. How to take Evrenzo 4. Possible side effects 5. How to store Evrenzo 6. Contents of the pack and other information 1. WHAT EVRENZO IS AND WHAT IT IS USED FOR WHAT EVRENZO IS Evrenzo is a medicine that increases the number of red blood cells and haemoglobin level in your blood. It contains the active substance roxadustat. WHAT EVRENZO IS USED FOR Evrenzo is used to treat adults with symptomatic anaemia that occurs in patients with chronic kidney disease. Anaemia is when you have too few red blood cells and your haemoglobin level is too low. As a result, your body might not receive enough oxygen. Anaemia can cause symptoms such as tiredness, weakness, or shortness of breath. HOW EVRENZO WORKS Roxadustat, the active substance in Evrenzo, works by increasing the level of HIF, a substance in the body which increases the production of red blood cells when oxygen levels are low. By raisin Lugege kogu dokumenti
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT Evrenzo 20 mg film-coated tablets Evrenzo 50 mg film-coated tablets Evrenzo 70 mg film-coated tablets Evrenzo 100 mg film-coated tablets Evrenzo 150 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Evrenzo 20 mg film-coated tablets Each tablet contains 20 mg of roxadustat. Evrenzo 50 mg film-coated tablets Each tablet contains 50 mg of roxadustat. Evrenzo 70 mg film-coated tablets Each tablet contains 70 mg of roxadustat. Evrenzo 100 mg film-coated tablets Each tablet contains 100 mg of roxadustat. Evrenzo 150 mg film-coated tablets Each tablet contains 150 mg of roxadustat. Excipient(s) with known effect Each 20 mg film-coated tablet contains 40.5 mg of lactose, 0.9 mg of Allura Red AC aluminium lake and 0.21 mg soya lecithin. Each 50 mg film-coated tablet contains 101.2 mg of lactose, 1.7 mg of Allura Red AC aluminium lake and 0.39 mg soya lecithin. Each 70 mg film-coated tablet contains 141.6 mg of lactose, 2.1 mg of Allura Red AC aluminium lake and 0.47 mg soya lecithin. Each 100 mg film-coated tablet contains 202.4 mg of lactose, 2.8 mg of Allura Red AC aluminium lake and 0.63 mg soya lecithin. Each 150 mg film-coated tablet contains 303.5 mg of lactose, 3.7 mg of Allura Red AC aluminium lake and 0.84 mg soya lecithin. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablets (tablets). Evrenzo 20 mg tablets Red, oval tablets (approximately 8 mm × 4 mm) with ‘20’ debossed on one side. Evrenzo 50 mg tablets Red, oval tablets (approximately 11 mm × 6 mm) with ‘50’ debossed on one side. Evrenzo 70 mg tablets 3 Red, round tablets (approximately 9 mm) with ‘70’ debossed on one side. Evrenzo 100 mg tablets Red, oval tab Lugege kogu dokumenti